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Epidemic transmission of West Nile virus (WNV) in 
Sacramento County, California, in 2005 prompted aerial 
application of pyrethrin, a mosquito adulticide, over a large 
urban area. Statistical analyses of geographic informa-
tion system datasets indicated that adulticiding reduced 
the number of human WNV cases within 2 treated areas 
compared with the untreated area of the county. When we 
adjusted for maximum incubation period of the virus from 
infection to onset of symptoms, no new cases were reported 
in either of the treated areas after adulticiding; 18 new cases 
were reported in the untreated area of Sacramento County 
during this time. Results indicated that the odds of infec-
tion after spraying were ≈6× higher in the untreated area 
than in treated areas, and that the treatments successfully 
disrupted the WNV transmission cycle. Our results provide 
direct evidence that aerial mosquito adulticiding is effective 
in reducing human illness and potential death from WNV 
infection.
W
est Nile virus (WNV; genus Flavivirus, family Flavi-
viridae) is transmitted to humans through the bite of 
an infected female mosquito and can cause clinical mani-
festations such as acute febrile illness, encephalitis, ﬂ  accid 
paralysis, and death (1). In California, WNV was ﬁ  rst iden-
tiﬁ  ed in 2003, during which time the virus was detected 
in 6 southern counties and 3 infected persons were identi-
ﬁ  ed (2). The following year, WNV spread northward from 
southern California to all 58 counties in the state, resulting 
in 779 human WNV cases and 28 deaths (3,4). In 2005, 
880 human WNV cases and 19 related deaths were iden-
tiﬁ  ed in California; 3,000 cases were reported nationwide 
(5,6). In contrast to 2004, when most of the WNV activity 
was concentrated in southern California, activity in 2005 
occurred primarily in the northern part of the Central Valley 
of California, where Sacramento County, the epicenter of 
WNV activity in the United States that year, had more hu-
man cases (163) than any other county in the nation (7).
In northern California, the principal urban and rural 
vectors of WNV are Culex pipiens and Cx. tarsalis, re-
spectively (8–10). To reduce WNV transmission and hu-
man exposure to mosquitoes in 2005, the Sacramento-Yolo 
Mosquito and Vector Control District (SYMVCD) imple-
mented a battery of control practices from their Integrated 
Pest Management plan (11), an ecosystem-based strategy 
focused on long-term control of mosquito populations (D. 
Brown, SYMVCD, pers. comm.). Despite the district’s in-
tensiﬁ  ed efforts (which began in March 2005) to control 
larval mosquitoes and to spot-treat for adult mosquitoes 
by using truck-mounted equipment, by August 2005 the 
county had reached the epidemic response level designated 
by the California Mosquito-Borne Virus Surveillance and 
Response Plan (12,13). Per the response plan, SYMVCD 
determined the appropriate response and control measures 
through the analysis of 8 surveillance factors, which pro-
vided a semiquantitative measure of transmission risk (D. 
Brown, pers. comm.). Rapidly escalating risk for WNV 
transmission to humans in Sacramento County was indi-
cated by high mosquito abundance and infection preva-
lence; high numbers of sentinel chicken seroconversions; 
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and record numbers of dead bird reports, equine cases, and 
human cases, including ≈24 conﬁ  rmed human infections 
by early August (8,10,14). Following state guidelines, and 
in consultation with local public health ofﬁ  cials, SYM-
VCD initiated aerial adulticiding in Sacramento County in 
August 2005 to rapidly reduce the abundance of infected 
mosquitoes and decrease the risk for WNV transmission to 
humans (D. Brown, pers. comm.). Despite a 60-year his-
tory of the aerial application of mosquito control products 
in California (15), this was the ﬁ  rst instance within the state 
of aerial adulticiding over a large urban area.
Although published studies on aerial application of 
adulticides have documented reductions in mosquito abun-
dance and infection prevalence along with concurrent or 
subsequent decreases in human cases (16–19), no published 
study to date has directly assessed the efﬁ  cacy of such 
control efforts in reducing incidence of human disease by 
comparing distribution of clinical cases within treated and 
untreated areas. The objective of our study was to evaluate 
the efﬁ  cacy of adulticide applications for reducing human 
cases of WNV; we compared the proportion and incidence 
of cases in the treated and untreated areas of Sacramento 
County in 2005 before and after aerial treatments. The pro-
portion and incidence of these cases were also compared 
with those of the rest of California.
Methods
Data Collection
Human WNV case data were reported to the California 
Department of Public Health from the Sacramento County 
Department of Health and Human Services and other local 
health departments throughout the state by using a stan-
dardized case history form. A total of 177 human infec-
tions were reported within Sacramento County in 2005, 
with onsets of illness ranging from June through October. 
Of 177 infections, 163 were clinical cases and 14 were as-
ymptomatic infections; the former was conﬁ  rmed by im-
munoglobulin (Ig) G and IgM antibody assays of serum 
or cerebrospinal ﬂ  uid samples. Of 163 case records, 7 had 
no date-of-onset information and 4 others had no residen-
tial address. Consequently, the Sacramento County human 
dataset used in this study comprised 152 records that con-
tained spatial and temporal attributes.
Residential addresses were imported into ArcMap 9.1 
geographic information systems software (Environmental 
Systems Research Institute, Inc., Redlands, CA, USA) and 
geocoded by using the software’s 2005 StreetMap USA 
Plus AltNames street dataset. All remaining unmatched 
addresses were geocoded by using Tele Atlas 2006 (Tele 
Atlas, Lebanon, NH, USA), NAVTEQ 2006 (NAVTEQ, 
Chicago, IL, USA.), GDT 2005 (Geographic Data Tech-
nology, Inc., Lebanon, NH, USA), and TIGER 2006 (US 
Census Bureau, Washington, DC, USA) datasets. Popula-
tion size estimates for the study areas deﬁ  ned below were 
calculated in ArcMap by selecting census blocks that had 
their center (centroid) in each deﬁ  ned region (Table 1) (20). 
All data were mapped by using the NAD83 USA Contigu-
ous Albers Equal Area Conic coordinate system.
Adulticide Application
Aerial adulticide applications were intended to create 
aerosolized clouds of insecticide that would contact, and 
consequently kill, airborne adult Culex spp. mosquitoes. 
SYMVCD targeted areas for treatment on the basis of levels 
of mosquito infection prevalence that had been previously as-
sociated with epidemic transmission within an urban setting 
(minimum infection rate per 1,000 female Culex spp. tested 
>5.0) (12). The district contracted with ADAPCO Vector 
Control Services (ADAPCO, Inc., Sanford, FL, USA) to ap-
ply adulticide by using 2 Piper Aztec aircraft (Piper Aircraft, 
Inc., Vero Beach, FL, USA) over an area of 222 km2 in north-
ern Sacramento County on the nights of August 8–10, 2005 
(northern treated area) and an area to the south of 255 km2 
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Table 1. Number of human cases of infection with West Nile virus by location and temporal classification, California, 2005* 
Area† Total Pretreatment‡ Posttreatment§ Postincubation¶ Population#
Treated, northern  34 28 6 0 221,828
Treated, southern  21 20 1 0 338,579
Buffer, northern  13 9 4 3 94,399
Buffer, southern  8 5 3 1 50,127
Untreated 76 41 35 18 518,566
Sacramento County  152 103 49 22 1,223,499
California 670 357 313 197 32,648,149
*Only cases with known date of onset of illness and location information (i.e., Sacramento County at the address level and California at the county level) 
are included in the analysis. 
†California excluding Sacramento County. 
‡Refers to cases with onset of illness up to and including the last date that aerial adulticiding was conducted (ending 22 Aug for the southern treated area 
and southern buffer zone and 10 Aug for all other areas). 
§Refers to cases with onset of illness after the last date that aerial adulticiding was conducted (beginning 23 Aug for the southern treated area and 
southern buffer zone and 11 Aug for all other areas). 
¶Refers to cases with onset of illness >14 days after the first date that aerial adulticiding was conducted (beginning 4 Sep for the southern treated area 
and southern buffer zone and 23 Aug for all other areas). 
#Population data source: UA Census 2000 TIGER/Line data made available in shapefile format through Environmental Systems Research Institute, Inc. 
(Redlands, CA, USA) (20). Mosquito Adulticide and WNV
on the nights of August 20–22, 2005 (southern treated area) 
(D. Brown, unpub. data) (Figure 1). Coverage was similar 
each night; repeated applications were intended to increase 
efﬁ  cacy (D. Brown, pers. comm.).
The applied compound was Evergreen EC 60–6 insec-
ticide (MGK, Minneapolis, MN, USA), a product composed 
of 6% pyrethrin/60% piperonyl butoxide (8). It was applied 
at the maximum rate according to the label, 0.0025 pounds 
of pyrethrins per acre (ultra-low volume dispersal), by 2 
Micronair AU4000 atomizer nozzles (Micron Sprayers, 
Ltd, Bromyard, Herefordshire, UK) on each aircraft, with 
a swath width of 1,300 feet and expected droplet spectrum 
volume mean diameters of 32.1 and 36.3 microns for the 2 
planes (D. Brown and G. Goodman, unpub. data). Condi-
tions during each night of spraying included wind speeds 
of 4–10 knots/h and temperatures/dew points of 27°C/14°C 
(northern treatment) and 33°C/12°C (southern treatment) 
(D. Brown, unpub. data). Planes began ﬂ  ying at ≈8:00 PM 
each night and ﬂ  ew for 3–6 h at 130 knots/h (D. Brown, 
unpub. data). The aircraft ﬂ  ew at altitudes of 61.0 m in the 
northern treated area and 91.4 m (because of obstacles such 
as tall towers and buildings) in the southern treated area 
(R. Laffey, SYMVCD, unpub. data, D. Markowski, pers. 
comm.). The Wingman GX aerial guidance and recording 
system (ADAPCO, Inc.), coupled with the Aircraft Inte-
grated Meteorological Management System (AIMMS-20; 
Aventech Research, Inc., Barrie, Ontario, Canada), mod-
eled the effective drift of released compounds on the ba-
sis of real-time meteorologic conditions (D. Brown, pers. 
comm.). Flight and treatment data were imported into Arc-
Map for mapping and analysis.
Case Classiﬁ  cation and Analysis
Despite the spray drift modeling systems’ high de-
gree of accuracy, variable and incomplete spray applica-
tion was expected at the edges of the modeled spray cloud 
(D. Markowski, pers. comm.). Factors contributing to this 
phenomenon include the intrinsic margin of error of the 
aircrafts’ spray drift modeling systems, the extrinsic mar-
gin of error caused by factors not detectable or taken into 
account by the modeling system (i.e., wind gusts, minor 
changes in aircraft altitude or speed, and other operational 
variables), and nonoverlapping spray clouds during dif-
ferent nights of application (D. Markowski, pers. comm.). 
Through consultation with ADAPCO, Inc., this variable 
and incomplete application at the perimeter was taken into 
account by delineating a 0.8-km (0.5-mile) buffer within 
the outermost range of the modeled spray clouds for each 
treated area (D. Markowski, pers. comm.). Nonbuffered ar-
eas of the spray regions (henceforth referred to as treated 
areas) were considered the most accurate representation of 
the actual spray application for this analysis, and any WNV 
cases that occurred within buffer zones were considered 
separately from those within treated areas. All human cases 
from Sacramento County that did not occur within treated 
areas or buffer zones were assigned to the untreated subset 
of cases, which served as the comparison (control) group 
for this study.
Cases were further classiﬁ  ed by date of onset of illness 
into pretreatment and posttreatment groups; temporal clas-
siﬁ  cation for the untreated area and the rest of California 
followed that of the northern treated area (Table 1). Be-
cause of the relatively lengthy and variable human WNV 
incubation period, persons who became infected just before 
the spray events could have become symptomatic up to 14 
days later (22,23). To exclude from analysis any infections 
that may have been acquired just before the spray events, 
posttreatment cases that had an onset of illness >14 days 
after spraying (counting from the ﬁ  rst night of application) 
were also included in a postincubation subset.
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Figure 1. Map of northern and southern aerial adulticiding treatment 
areas in Sacramento County, California, 2005, showing the 2 urban 
areas treated by the Sacramento-Yolo Mosquito and Vector Control 
District (SYMVCD). Horizontal bars represent swaths of spray 
clouds created by individual passes of the aircraft, as deﬁ  ned by 
the spray drift modeling systems. Gaps within spray clouds were 
caused by factors such as towers and buildings that altered the 
ﬂ  ight of the aircraft (G. Goodman, SYMVCD, pers. comm.). These 
gaps were assumed to have negligible effect in this study; no human 
cases occurred within any gaps. Gray region surrounding much of 
the spray zones represents the urbanized area of Sacramento; 
urbanized area is deﬁ  ned by the US Census Bureau as a densely 
settled territory that contains >50,000 persons (21). For display 
purposes, we used the NAD83 HARN California II State Plane 
coordinate system (Lambert Conformal Conic projection). Inset 
shows location of treatment areas in California.RESEARCH
The null hypothesis, that the proportion of cases in 
treated and untreated areas was equal to that of the respec-
tive population size estimates, was tested for pretreatment 
and posttreatment groups with the exact binomial test for 
goodness of ﬁ  t by using VassarStats (http://faculty.vassar.
edu/lowry/VassarStats.html). Second, signiﬁ  cance of pro-
portions of human cases before and after spraying within 
treated and untreated areas was evaluated with the Fisher 
exact test of independence by using SAS version 9.1.3 
(SAS Institute Inc., Cary, NC, USA). The null hypothesis 
of this test was that there was no signiﬁ  cant association 
between occurrence of adulticiding and temporal classiﬁ  -
cation of cases (i.e., pretreatment or posttreatment). Third, 
relative risk (RR) and odds ratio (OR) of infection in the 
untreated area compared with those in treated areas were 
calculated by using cumulative incidence of WNV in each 
region before and after spraying (24). To evaluate whether 
buffer zones had any effect on results, all calculations were 
repeated by using cases from buffer zones and treated areas 
combined, as well as cases from buffer zones alone.
Assumptions
As is standard practice in most epidemiologic studies, 
residential addresses of patients were assumed to be loca-
tions of disease transmission; this is also consistent with 
other WNV studies (25–31). The assumption that WNV 
was transmitted to persons at their place of residence is sup-
ported by the fact that WNV mosquito vectors feed primar-
ily from dusk to dawn, and also by ﬁ  ndings that persons 
who spent >2 h outdoors during this time without wearing 
insect repellant had the highest WNV seroprevalence  (31).
Because of the random sampling requirement for tests 
of statistical signiﬁ   cance, we must assume that various 
human populations had an equal likelihood of becoming 
clinically ill before aerial treatment and that no preexisting 
factors contributed to a differential in disease experience. 
Although construction of a multilevel, spatial correlation 
model is beyond the scope of this study, several impor-
tant properties of the populations sufﬁ  ciently support our 
assumption of homogeneity. Despite the geographic size 
of the untreated area being ≈6× that of the treated areas 
combined (2,101 vs. 361 km2, Figure 2), population size 
estimates of both areas were comparable (518,566 vs. 
560,407, Table 1) (20). Furthermore, the preponderance of 
cases in the treated (100%, 55/55), buffer (95%, 20/21), 
and untreated (87%, 66/76) areas was located within the 
urbanized area of Sacramento, which constitutes 27% (686 
of 2,578 km2) of the total area of the county (Figure 1) (20). 
Additionally, most cases in the untreated area were located 
either between the northern and southern treated areas or 
immediately north of the northern treated area, and >94% 
(143/152) of all cases were located within 4.8 km (3 miles) 
of treated areas. This staggered conﬁ  guration of treated 
and untreated areas, along with the general proximity of 
cases within 1 urban region, supported the assumption of 
homogeneity of populations at risk and created a natural 
experiment for comparative analyses between treated and 
untreated areas.
Results
The observed proportion of pretreatment cases in treat-
ed areas to those in the untreated area was not signiﬁ  cantly 
different from the expected proportion on the basis of popu-
lation size estimates (p = 0.7508, Table 2). Similarly, none 
of the proportions of pretreatment cases in any combination 
of treated areas and buffer zones were different from those 
of the untreated area. However, after adulticiding, all pro-
portions of cases in treated areas were lower than that in the 
untreated area. Proportions of posttreatment cases in buffer 
zones were not different from those in the untreated area.
There was a signiﬁ  cantly lower proportion of post-
treatment cases within combined treated areas compared 
with that in the untreated area (p<0.0001, Table 2). Pro-
portions of posttreatment to pretreatment cases within 
each of the individual treated areas were also signiﬁ  cantly 
lower than that for the untreated area (northern treated area 
p = 0.0053; southern treated area p = 0.0003). After com-
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Figure 2. Locations of treated areas and human cases of West Nile 
virus by temporal classiﬁ   cation, Sacramento County, California, 
2005. Shown are treated areas (dark gray), surrounding 0.8-km 
buffers (thin regions around dark gray areas), untreated areas (light 
gray), and location of human cases within each of these regions 
(red, blue, and green circles, respectively). For display purposes, 
we used the NAD83 HARN California II State Plane coordinate 
system (Lambert Conformal Conic projection).Mosquito Adulticide and WNV
bining cases from treated areas and buffer zones, propor-
tions of posttreatment versus pretreatment cases were again 
signiﬁ   cantly lower (both treated areas plus buffers p = 
0.0005; northern treated area plus buffer p = 0.0069; south-
ern treated area plus buffer p = 0.0029). However, none of 
the proportions of posttreatment versus pretreatment cases 
in buffer zones alone compared with those in the untreated 
area were signiﬁ  cantly different (both buffer zones p = 
0.3309; northern buffer zone p = 0.3745; southern buffer 
zone p = 0.7237).
The last human case that occurred in treated areas had 
an onset of illness 12 days after inception of spraying, within 
the 14-day maximum range of the human WNV incubation 
period. Thus, when the incubation period was taken into 
account, there were no new human WNV cases reported in 
either treated area after adulticiding (postincubation cases, 
Table 1, Figure 3). In contrast, 18 new cases were reported 
from the untreated area during this time; the last case oc-
curred 59 days after inception of spraying. The frequency 
of these postincubation cases relative to the overall number 
of cases in the untreated area (24%) was consistent with 
that for the rest of the state (29%) but inconsistent with that 
for treated areas (0%).
Normalizing number of cases in each region by re-
spective population size estimate showed the increase in 
incidence levels throughout the year (Figure 4). Statewide 
(excluding Sacramento County and cases without onset 
data), cumulative incidence in 2005 was 2.1/100,000 popu-
lation, and the temporal pattern of incidence throughout 
the year was similar to that of the untreated area. On the 
basis of cumulative incidence within each region before 
aerial treatment, RR for the untreated area compared with 
that for treated areas was 0.9231 (95% conﬁ  dence interval 
[CI] 0.6085–1.400), which did not differ from unity. After 
treatment, RR was 5.403 (95% CI 2.400–12.16), with an 
OR of 5.853 (5.403/0.9231, 95% CI 2.351–14.58) in fa-
vor of infection in the untreated area than in treated areas; 
RR and OR differed from unity. Similarly, RRs for the un-
treated area compared with those for treated areas and buf-
fer zones combined were 0.8990 (95% CI 0.6059–1.334) 
and 3.398 (95% CI 1.829–6.316) before and after adulti-
ciding, respectively, with an OR of 3.780 (3.398/0.8990, 
95% CI 1.813–7.882). Conversely, RRs for the untreated 
area versus the buffer zones alone were 0.8162 (95% CI 
0.4450–1.497) and 1.393 (95% CI 0.6190–3.137) before 
and after adulticiding, respectively, with an OR of 1.707 
(1.393/0.8162, 95% CI 0.6198–4.703); the RRs and OR did 
not differ from unity.
Discussion
Evaluation of efﬁ  cacy is essential for assessing ap-
propriateness of insecticide applications. However, such 
studies assessing the ability of adulticides to directly affect 
human incidence of WNV have been nonexistent. Our ﬁ  nd-
ings, coupled with corroborating evidence of a reduction in 
the abundance of Cx. pipiens (8), indicate that aerial appli-
cation of pyrethrin in 2005 successfully disrupted the WNV 
transmission cycle, and that this treatment was responsible 
for an abrupt decrease in the number of human cases with-
in treated areas compared with that in the untreated area. 
These results provide direct evidence that aerial spraying to 
control adult mosquitoes effectively reduced human illness 
and potential deaths from WNV infection.
With respect to population size estimates, proportions 
of pretreatment cases in all treated areas and buffer zones 
were not different from that in the untreated area, which 
validates comparability of the baseline populations. Simi-
larly, none of the pretreatment RRs deviated from unity, 
which supports the assumption that treated and untreated 
areas had an equal likelihood, on the basis of population 
size, of containing a clinical case before the adulticiding, 
and that no preexisting factors contributed to differing dis-
ease incidence rates during that time. These conditions are 
important for verifying that the untreated area was a valid 
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Table 2. Statistical test results for West Nile virus cases, Sacramento County, California, 2005* 
Goodness of fit†  Independence‡
Area Pretreatment  Posttreatment Posttreatment vs. pretreatment 
Treated, both  0.7508 <0.0001 <0.0001
Treated, northern  0.0650 0.0391 0.0053
Treated, southern  0.2983 <0.0001 0.0003
Treated plus buffer, both  0.6195 <0.0001 0.0005
Treated plus buffer, northern  0.1015 0.0314 0.0069
Treated plus buffer, southern  0.4568 <0.0001 0.0029
Buffer, both  0.5140 0.5744 0.3309
Buffer, northern  0.5592 0.5065 0.3745
Buffer, southern  0.5990 1.0000 0.7237
*Numbers of cases were combined for multiple areas; geographically corresponding buffer zones were added where noted. Numbers are 2-tailed p 
values. Statistically significant associations (p<0.05) are in boldface.
†Exact binomial goodness-of-fit test for observed proportion of cases in listed area(s) to cases in untreated area compared with the expected proportion 
based on population size estimates. 
‡Fisher exact test of independence for 2 × 2 contingency tables containing numbers of pretreatment and posttreatment cases for listed area(s) and the 
untreated area. RESEARCH
comparison group for use in statistical analyses.
Comparisons of buffer zones with the untreated area 
indicated no differences between posttreatment RR or 
the proportions of posttreatment cases within the 2 areas, 
which supports the assumption of reduced spray efﬁ  cacy at 
the perimeter of the modeled spray cloud. This ﬁ  nding may 
have implications for future aerial applications and efﬁ  cacy 
studies. Additionally, posttreatment inﬁ  ltration of Cx. tar-
salis mosquitoes from bordering untreated areas has been 
a previously documented phenomenon in California and 
Texas (19,32–34). On the basis of mean dispersal distances 
of Cx. tarsalis (0.88 km) and Cx. pipiens quinquefasciatus 
(1.10 km) in California (35), use of the 0.8-km buffer in 
this study also reduced the probability of including in the 
treatment groups any human infections contracted through 
posttreatment mosquito inﬁ  ltration. However, results of all 
statistical tests remained unchanged after combining the 
number of cases from buffer zones and treated areas, and 
these posttreatment reductions of cases still differed from 
that in the untreated area (Table 2).
Because posttreatment proportions of cases were lower 
than in the untreated area, we rejected the null hypothesis of 
goodness-of-ﬁ  t comparisons. Our results also indicate that 
there were associations between adulticiding and temporal 
classiﬁ  cation of cases. Therefore, we also rejected the null 
hypothesis of tests of independence. Furthermore, odds of 
infection after spraying were ≈6× higher in the untreated 
area than in treated areas. Without applications of aerial 
adulticide, more Sacramento residents would have been in-
fected with WNV. This ﬁ  nding supports federal and Cali-
fornia WNV response recommendations, which state that 
“mosquito adulticiding may be the only practical control 
technique available in situations where surveillance data 
indicate that it is necessary to reduce the density of adult 
mosquito populations quickly to lower the risk of WNV 
transmission to humans” (36).
Although there was a negative correlation between 
aerial treatments and incidence of human cases, causation 
is predicated upon spraying having a direct effect on mos-
quito populations. Recent work showed that adulticiding 
immediately reduced abundance and infection rates of 
Culex spp. mosquitoes compared with rates in an untreated 
area (8). Using factorial 2-way analysis of variance, these 
researchers compared mean abundances of Cx. pipiens and 
Cx. tarsalis from CO2-baited traps (46 trap nights) in the 
northern treated area with mean abundances from traps (55 
trap nights) in similar urban-suburban habitats within the 
untreated area of Sacramento County and adjacent Yolo 
County, 1 week before and 1 week after the August 8 
spraying. Abundance of Cx. pipiens decreased by 75.0%, 
and there was a signiﬁ  cant interaction between adulticiding 
and temporal classiﬁ  cation (F 4.965, df 1,47, p = 0.031). 
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Figure 3. Human cases of West Nile virus (WNV), Sacramento 
County, California, 2005, by region and date of onset of illness. 
Black bars show cases within untreated area; gray bars show 
cases within northern and southern treated areas combined; 
and white bars show cases within northern and southern buffer 
zones combined. Values along the x-axis (days) are grouped into 
sets of 3 and labeled with the date farthest from 0. Each of the 
3 days of adulticiding within the treated areas and buffer zones 
was considered to be 0; for the untreated area, the dates of the 
northern adulticiding (August 8–10) were considered to be 0. 
The wide gray vertical band represents time from the ﬁ  rst day of 
treatment to the maximum range of the human WNV incubation 
period 14 days later.
Figure 4. Cumulative incidence of human cases of West Nile virus 
(WNV) in Sacramento County and California, 2005. Only cases 
with known date of onset of illness and location information (i.e., 
Sacramento County at the address level and California at the county 
level) are included in the analysis. Cumulative incidence is the total 
no. WNV cases/100,000 population. Green line shows incidence 
within untreated area; red line shows incidence within northern 
treated area; yellow line shows incidence within southern treated 
area; blue line shows incidence within northern and southern buffer 
zones combined; black line shows incidence within California, 
excluding Sacramento County. Values along the x-axis (days) are 
grouped into sets of 3 and labeled with the date farthest from 0. 
Each of the 3 days of adulticiding within the treated areas and buffer 
zones was considered to be 0; for the untreated area and the rest 
of California, the dates of the northern adulticiding (August 8–10) 
were considered to be 0. The wide gray vertical band represents 
time from the ﬁ  rst day of treatment to the maximum range of the 
human WNV incubation period 14 days later.Mosquito Adulticide and WNV
Abundance of Cx. tarsalis decreased by 48.7% but the in-
teraction was not statistically signiﬁ  cant (F 0.754, df 1,47, 
p = 0.390). As stated by these researchers, this disparity 
may have been caused by the presence of “an increasing 
population of Cx. pipiens and an already declining popula-
tion of Cx. tarsalis” at the time of the spraying, and because 
Cx. tarsalis breeds principally in rural areas. Regardless, 
we reason that Cx. pipiens was the primary vector in the 
Sacramento County epidemic because this species is the 
principal urban vector in this region (8–10), was the most 
abundant species collected in Sacramento County in 2005 
(D.-E.A. Elnaiem, unpub. data), and comprised the high-
est percentage of WNV-infected mosquito pools (68.3% 
versus 28.8% for Cx. tarsalis) in Sacramento County that 
same year (10).
Additionally, these researchers combined mosquitoes 
of both species (into pools of <50 females) taken from 
aforementioned traps and others in the northern treated area 
and untreated area 2 weeks before and 2 weeks after the 
August 8 adulticiding. Pools of mosquitoes were tested for 
WNV by using a reverse transcription–polymerase chain 
reaction, and infection rates were calculated by using a 
bias-corrected maximum likelihood estimation (www.cdc.
gov/ncidod/dvbid/westnile/software.htm). After spraying, 
infection rates decreased from 8.2 (95% CI 3.1–18.0) to 4.3 
(95% CI 0.3–20.3) per 1,000 females in the spray area and 
increased from 2.0 (95% CI 0.1–9.7) to 8.7 (95% CI 3.3–
18.9) per 1,000 females in the untreated area. Furthermore, 
no additional positive pools were detected in the northern 
treatment area during the remainder of the year, whereas 
positive pools were detected in the untreated area until the 
end of September (D.-E.A. Elnaiem, unpub. data). These 
independent lines of evidence corroborate our conclusion 
that actions taken by SYMVCD were effective in disrupt-
ing the WNV transmission cycle and reducing human ill-
ness and potential deaths associated with WNV.
Historically, human WNV cases in the United States 
peak in August (37,38). This pattern was observed in Sac-
ramento County and the rest of California in 2005, in which 
61% (93/152) and 47% (314/670), respectively, of human 
cases had onset of illness in August. The next highest month 
was July, during which 27% (41/152) and 29% (195/670) 
of human cases had onset of illness in the county and the 
rest of the state, respectively. These ﬁ  ndings are consistent 
with others from Sacramento County in 2005, which indi-
cated that mosquito infection rates peaked in July and Au-
gust (10). Considering early summer ampliﬁ  cation within 
vector populations and length of the human incubation pe-
riod, WNV remediation efforts would be more effective in 
limiting illness and death associated with human infection 
if conducted at the onset of enzootic ampliﬁ  cation rather 
than after occurrence of human cases.
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